356 related articles for article (PubMed ID: 25288399)
1. The transcription factors IRF8 and PU.1 negatively regulate plasma cell differentiation.
Carotta S; Willis SN; Hasbold J; Inouye M; Pang SH; Emslie D; Light A; Chopin M; Shi W; Wang H; Morse HC; Tarlinton DM; Corcoran LM; Hodgkin PD; Nutt SL
J Exp Med; 2014 Oct; 211(11):2169-81. PubMed ID: 25288399
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4.
Ochiai K; Maienschein-Cline M; Simonetti G; Chen J; Rosenthal R; Brink R; Chong AS; Klein U; Dinner AR; Singh H; Sciammas R
Immunity; 2013 May; 38(5):918-29. PubMed ID: 23684984
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination.
Klein U; Casola S; Cattoretti G; Shen Q; Lia M; Mo T; Ludwig T; Rajewsky K; Dalla-Favera R
Nat Immunol; 2006 Jul; 7(7):773-82. PubMed ID: 16767092
[TBL] [Abstract][Full Text] [Related]
4. Transcription factors IRF8 and PU.1 are required for follicular B cell development and BCL6-driven germinal center responses.
Wang H; Jain S; Li P; Lin JX; Oh J; Qi C; Gao Y; Sun J; Sakai T; Naghashfar Z; Abbasi S; Kovalchuk AL; Bolland S; Nutt SL; Leonard WJ; Morse HC
Proc Natl Acad Sci U S A; 2019 May; 116(19):9511-9520. PubMed ID: 31000603
[TBL] [Abstract][Full Text] [Related]
5. Alternate pathways for Bcl6-mediated regulation of B cell to plasma cell differentiation.
Alinikula J; Nera KP; Junttila S; Lassila O
Eur J Immunol; 2011 Aug; 41(8):2404-13. PubMed ID: 21674482
[TBL] [Abstract][Full Text] [Related]
6. Positive regulatory domain I (PRDM1) and IRF8/PU.1 counter-regulate MHC class II transactivator (CIITA) expression during dendritic cell maturation.
Smith MA; Wright G; Wu J; Tailor P; Ozato K; Chen X; Wei S; Piskurich JF; Ting JP; Wright KL
J Biol Chem; 2011 Mar; 286(10):7893-7904. PubMed ID: 21216962
[TBL] [Abstract][Full Text] [Related]
7. miR-148a promotes plasma cell differentiation and targets the germinal center transcription factors Mitf and Bach2.
Porstner M; Winkelmann R; Daum P; Schmid J; Pracht K; Côrte-Real J; Schreiber S; Haftmann C; Brandl A; Mashreghi MF; Gelse K; Hauke M; Wirries I; Zwick M; Roth E; Radbruch A; Wittmann J; Jäck HM
Eur J Immunol; 2015 Apr; 45(4):1206-15. PubMed ID: 25678371
[TBL] [Abstract][Full Text] [Related]
8. Transcription factors PU.1 and IRF4 regulate activation induced cytidine deaminase in chicken B cells.
Luo H; Tian M
Mol Immunol; 2010 Apr; 47(7-8):1383-95. PubMed ID: 20299102
[TBL] [Abstract][Full Text] [Related]
9. IRF8 regulates B-cell lineage specification, commitment, and differentiation.
Wang H; Lee CH; Qi C; Tailor P; Feng J; Abbasi S; Atsumi T; Morse HC
Blood; 2008 Nov; 112(10):4028-38. PubMed ID: 18799728
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.
White CA; Pone EJ; Lam T; Tat C; Hayama KL; Li G; Zan H; Casali P
J Immunol; 2014 Dec; 193(12):5933-50. PubMed ID: 25392531
[TBL] [Abstract][Full Text] [Related]
11. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation.
Sciammas R; Shaffer AL; Schatz JH; Zhao H; Staudt LM; Singh H
Immunity; 2006 Aug; 25(2):225-36. PubMed ID: 16919487
[TBL] [Abstract][Full Text] [Related]
12. PU.1 cooperates with IRF4 and IRF8 to suppress pre-B-cell leukemia.
Pang SH; Minnich M; Gangatirkar P; Zheng Z; Ebert A; Song G; Dickins RA; Corcoran LM; Mullighan CG; Busslinger M; Huntington ND; Nutt SL; Carotta S
Leukemia; 2016 Jun; 30(6):1375-87. PubMed ID: 26932576
[TBL] [Abstract][Full Text] [Related]
13. Bach2 represses plasma cell gene regulatory network in B cells to promote antibody class switch.
Muto A; Ochiai K; Kimura Y; Itoh-Nakadai A; Calame KL; Ikebe D; Tashiro S; Igarashi K
EMBO J; 2010 Dec; 29(23):4048-61. PubMed ID: 20953163
[TBL] [Abstract][Full Text] [Related]
14. IRF8-dependent molecular complexes control the Th9 transcriptional program.
Humblin E; Thibaudin M; Chalmin F; Derangère V; Limagne E; Richard C; Flavell RA; Chevrier S; Ladoire S; Berger H; Boidot R; Apetoh L; Végran F; Ghiringhelli F
Nat Commun; 2017 Dec; 8(1):2085. PubMed ID: 29233972
[TBL] [Abstract][Full Text] [Related]
15. IRF4 Is a Critical Gene in Retinoic Acid-Mediated Plasma Cell Formation and Is Deregulated in Common Variable Immunodeficiency-Derived B Cells.
Indrevær RL; Moskaug JØ; Paur I; Bøhn SK; Jørgensen SF; Blomhoff R; Aukrust P; Fevang B; Blomhoff HK
J Immunol; 2015 Sep; 195(6):2601-11. PubMed ID: 26276871
[TBL] [Abstract][Full Text] [Related]
16. Regulatory mechanisms that determine the development and function of plasma cells.
Calame KL; Lin KI; Tunyaplin C
Annu Rev Immunol; 2003; 21():205-30. PubMed ID: 12524387
[TBL] [Abstract][Full Text] [Related]
17. PU.1 and IRF8 Modulate Activation of NLRP3 Inflammasome
Yashiro T; Yamamoto M; Araumi S; Hara M; Yogo K; Uchida K; Kasakura K; Nishiyama C
Front Immunol; 2021; 12():649572. PubMed ID: 33897697
[TBL] [Abstract][Full Text] [Related]
18. BLIMP-1 is insufficient to induce antibody secretion in the absence of IRF4 in DT40 cells.
Budzyńska PM; Kyläniemi MK; Lassila O; Nera KP; Alinikula J
Scand J Immunol; 2018 Mar; 87(3):. PubMed ID: 29430664
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation.
Minnich M; Tagoh H; Bönelt P; Axelsson E; Fischer M; Cebolla B; Tarakhovsky A; Nutt SL; Jaritz M; Busslinger M
Nat Immunol; 2016 Mar; 17(3):331-43. PubMed ID: 26779602
[TBL] [Abstract][Full Text] [Related]
20. IRF4 - a factor for class switching and antibody secretion.
Fillatreau S; Radbruch A
Nat Immunol; 2006 Jul; 7(7):704-6. PubMed ID: 16785887
[No Abstract] [Full Text] [Related]
[Next] [New Search]
